Variant GADL1 and response to lithium in bipolar I disorder

Hou, Liping; Heilbronner, Urs; Rietschel, Marcella; Kato, Tadafumi; Kuo, Po-Hsiu; McMahon, Francis J; Schulze, Thomas G; Aubry, Jean-Michel; Consortium on lithium genetics (CoLinGen)

doi:10.1056/NEJMc1401817#SA4

Professional article

English

Variant GADL1 and response to lithium in bipolar I disorder

ContributorsHou, Liping; Heilbronner, Urs; Rietschel, Marcella; Kato, Tadafumi; Kuo, Po-Hsiu; McMahon, Francis J; Schulze, Thomas G; Aubry, Jean-Michel; Consortium on lithium genetics (CoLinGen)

Published inThe New England journal of medicine, vol. 370, no. 19, p. 1857-1859

Publication date2014

Keywords

Antimanic Agents/therapeutic use
Bipolar Disorder/genetics
Carboxy-Lyases/genetics
Female
Humans
Lithium/therapeutic use
Male
Polymorphism, Single Nucleotide

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de psychiatrie

Research groups

Thérapeutiques des Troubles de l'Humeur et Anxieux (689)

Citation (ISO format)

HOU, Liping et al. Variant GADL1 and response to lithium in bipolar I disorder. In: The New England journal of medicine, 2014, vol. 370, n° 19, p. 1857–1859. doi: 10.1056/NEJMc1401817#SA4

Article (Published version)

Identifiers

PID : unige:41823
DOI : 10.1056/NEJMc1401817#SA4
PMID : 24806176

Journal ISSN0028-4793

564views

258downloads

Creation07/10/2014 10:59:00

First validation07/10/2014 10:59:00

Update time14/03/2023 22:15:13

Status update14/03/2023 22:15:12

Last indexation30/10/2024 20:44:34

Archive ouverte UNIGE

Variant GADL1 and response to lithium in bipolar I disorder

Technical informations